{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:03:46Z","timestamp":1793577826640,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-024-01649-8","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T01:18:02Z","timestamp":1735175882000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Therapeutic implications of necroptosis activation in Alzheimer\u00b4s disease"],"prefix":"10.1186","volume":"16","author":[{"given":"Elizabeth","family":"Carrazana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Salvadores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,26]]},"reference":[{"key":"1649_CR1","unstructured":"Alzheimer\u2019s A. 2023 Alzheimer\u2019s disease facts and figures. Alzheimers Dement [Internet]. 2023;19(4):1598\u2013695. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/36918389"},{"key":"1649_CR2","doi-asserted-by":"crossref","unstructured":"Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P et al. Mutation of the \u03b2-amyloid precursor protein in familial Alzheimer\u2019s disease increases \u03b2-protein production. Nature [Internet]. 1992;360(6405):672\u20134. http:\/\/www.nature.com\/articles\/360672a0","DOI":"10.1038\/360672a0"},{"issue":"3","key":"1649_CR3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/ng0692-218","volume":"1","author":"L Hendriks","year":"1992","unstructured":"Hendriks L, van Duijn CM, Cras P, Cruts M, Van Hul W, van Harskamp F, et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the \u03b2\u2013amyloid precursor protein gene. Nat Genet. 1992;1(3):218\u201321.","journal-title":"Nat Genet"},{"key":"1649_CR4","doi-asserted-by":"crossref","unstructured":"Suzuki N, Cheung T, Cai X, Odaka A, Otvos L, Eckman C et al. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science (1979) [Internet]. 1994;264(5163):1336\u201340. http:\/\/www.nature.com\/articles\/nrd2896","DOI":"10.1126\/science.8191290"},{"issue":"9","key":"1649_CR5","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1136\/jnnp.74.9.1206","volume":"74","author":"RJ Harvey","year":"2003","unstructured":"Harvey RJ, Skelton-Robinson M, Rossor MN. The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry. 2003;74(9):1206\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1649_CR6","doi-asserted-by":"crossref","unstructured":"Farrer LA. Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease. JAMA [Internet]. 1997;278(16):1349. http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.1997.03550160069041","DOI":"10.1001\/jama.1997.03550160069041"},{"issue":"8006","key":"1649_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41586-024-07185-7","volume":"628","author":"MS Haney","year":"2024","unstructured":"Haney MS, P\u00e1lovics R, Munson CN, Long C, Johansson PK, Yip O, et al. APOE4\/4 is linked to damaging lipid droplets in Alzheimer\u2019s disease microglia. Nature. 2024;628(8006):154\u201361.","journal-title":"Nature"},{"key":"1649_CR8","doi-asserted-by":"publisher","unstructured":"Alzheimer A. 2024 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s & Dementia [Internet]. 2024;20(5):3708\u2013821. https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/alz.13809","DOI":"10.1002\/alz.13809"},{"key":"1649_CR9","doi-asserted-by":"publisher","unstructured":"Lautenschlager NT, Cupples LA, Rao VS, Auerbach SA, Becker R, Burke J et al. Risk of dementia among relatives of Alzheimer\u2019s disease patients in the MIRAGE study. Neurology [Internet]. 1996;46(3):641\u201350. https:\/\/www.neurology.org\/doi\/https:\/\/doi.org\/10.1212\/WNL.46.3.641","DOI":"10.1212\/WNL.46.3.641"},{"key":"1649_CR10","doi-asserted-by":"crossref","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet. Volume 396. Lancet Publishing Group; 2020. pp. 413\u201346.","DOI":"10.1016\/S0140-6736(20)30367-6"},{"issue":"11","key":"1649_CR11","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak H, Thal DR, Ghebremedhin E, Del Tredici K. Stages of the pathologic process in alzheimer disease: Age categories from 1 to 100 years. J Neuropathol Exp Neurol. 2011;70(11):960\u20139.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1649_CR12","doi-asserted-by":"crossref","unstructured":"Jack CR, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS et al. Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. 12, The Lancet Neurology. 2013. pp. 207\u201316.","DOI":"10.1016\/S1474-4422(12)70291-0"},{"issue":"3","key":"1649_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","volume":"17","author":"BA Gordon","year":"2018","unstructured":"Gordon BA, Blazey TM, Su Y, Hari-Raj A, Dincer A, Flores S, et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer\u2019s disease: a longitudinal study. Lancet Neurol. 2018;17(3):241\u201350.","journal-title":"Lancet Neurol"},{"issue":"4","key":"1649_CR14","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, Khoury J, El, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14(4):388\u2013405.","journal-title":"Lancet Neurol"},{"key":"1649_CR15","doi-asserted-by":"crossref","unstructured":"Spires-Jones TL, Hyman BT. The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer\u2019s Disease. Neuron [Internet]. 2014;82(4):756\u201371. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896627314003900","DOI":"10.1016\/j.neuron.2014.05.004"},{"key":"1649_CR16","doi-asserted-by":"crossref","unstructured":"Gouras GK, Tampellini D, Takahashi RH, Capetillo-Zarate E. Intraneuronal \u03b2-amyloid accumulation and synapse pathology in Alzheimer\u2019s disease. Acta Neuropathol [Internet]. 2010;119(5):523\u201341. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3624763\/pdf\/nihms412728.pdf","DOI":"10.1007\/s00401-010-0679-9"},{"issue":"5","key":"1649_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ana.410270502","volume":"27","author":"ST DeKosky","year":"1990","unstructured":"DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in Alzheimer\u2019s disease: correlation with cognitive severity. Ann Neurol. 1990;27(5):457\u201364.","journal-title":"Ann Neurol"},{"issue":"1","key":"1649_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2051-5960-2-1","volume":"2","author":"LE Collins-Praino","year":"2014","unstructured":"Collins-Praino LE, Francis YI, Griffith EY, Wiegman AF, Urbach J, Lawton A, et al. Soluble amyloid beta levels are elevated in the white matter of Alzheimer\u2019s patients, independent of cortical plaque severity. Acta Neuropathol Commun. 2014;2(1):1\u201310.","journal-title":"Acta Neuropathol Commun"},{"issue":"Pt 12","key":"1649_CR19","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1093\/brain\/awt273","volume":"136","author":"CH Andrade-Moraes","year":"2013","unstructured":"Andrade-Moraes CH, Oliveira-Pinto AV, Castro-Fonseca E, da Silva CG, Guimar\u00e3es DM, Szczupak D, et al. Cell number changes in Alzheimer\u2019s disease relate to dementia, not to plaques and tangles. Brain. 2013;136(Pt 12):3738\u201352.","journal-title":"Brain"},{"key":"1649_CR20","doi-asserted-by":"publisher","unstructured":"Thal DR, R\u00fcb U, Orantes M, Braak H. Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD. Neurology [Internet]. 2002;58(12):1791\u2013800. http:\/\/www.neurology.org\/lookup\/doi\/https:\/\/doi.org\/10.1212\/WNL.58.12.1791","DOI":"10.1212\/WNL.58.12.1791"},{"key":"1649_CR21","doi-asserted-by":"crossref","unstructured":"Blinkouskaya Y, Weickenmeier J. Brain shape changes Associated with cerebral atrophy in healthy aging and Alzheimer\u2019s Disease. Front Mech Eng. 2021;7.","DOI":"10.3389\/fmech.2021.705653"},{"key":"1649_CR22","doi-asserted-by":"crossref","unstructured":"Moujalled D, Strasser A, Liddell JR. Molecular mechanisms of cell death in neurological diseases. Cell Death and Differentiation. Volume 28. Springer Nature; 2021. pp. 2029\u201344.","DOI":"10.1038\/s41418-021-00814-y"},{"key":"1649_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neurobiolaging.2020.06.022","volume":"95","author":"DL Brokaw","year":"2020","unstructured":"Brokaw DL, Piras IS, Mastroeni D, Weisenberger DJ, Nolz J, Delvaux E, et al. Cell death and survival pathways in Alzheimer\u2019s disease: an integrative hypothesis testing approach utilizing -omic data sets. Neurobiol Aging. 2020;95:15\u201325.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"1649_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00401-022-02528-y","volume":"145","author":"S Moonen","year":"2023","unstructured":"Moonen S, Koper MJ, Van Schoor E, Schaeverbeke JM, Vandenberghe R, von Arnim CAF, et al. Pyroptosis in Alzheimer\u2019s disease: cell type-specific activation in microglia, astrocytes and neurons. Acta Neuropathol. 2023;145(2):175\u201395.","journal-title":"Acta Neuropathol"},{"key":"1649_CR25","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nm.3232","volume":"19","author":"RA Nixon","year":"2013","unstructured":"Nixon RA. The role of autophagy in neurodegenerative disease. Nat Med. 2013;19:983\u201397.","journal-title":"Nat Med"},{"issue":"7","key":"1649_CR26","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1007\/s12035-018-1403-3","volume":"56","author":"A Weiland","year":"2019","unstructured":"Weiland A, Wang Y, Wu W, Lan X, Han X, Li Q, et al. Ferroptosis and its role in Diverse Brain diseases. Mol Neurobiol. 2019;56(7):4880\u201393.","journal-title":"Mol Neurobiol"},{"key":"1649_CR27","doi-asserted-by":"publisher","unstructured":"Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M et al. Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation. Cell [Internet]. 2009;137(6):1112\u201323. https:\/\/doi.org\/10.1016\/j.cell.2009.05.037","DOI":"10.1016\/j.cell.2009.05.037"},{"key":"1649_CR28","doi-asserted-by":"publisher","unstructured":"Degterev A, Hitomi J, Germscheid M, Ch\u2019 IL, Korkina O, Teng X et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol [Internet]. 2008;4(5):313\u201321. http:\/\/www.nature.com\/doifinder\/https:\/\/doi.org\/10.1038\/nchembio.83","DOI":"10.1038\/nchembio.83"},{"key":"1649_CR29","doi-asserted-by":"publisher","unstructured":"Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol [Internet]. 2005;1(2):112\u20139. http:\/\/www.nature.com\/doifinder\/https:\/\/doi.org\/10.1038\/nchembio711","DOI":"10.1038\/nchembio711"},{"issue":"6","key":"1649_CR30","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.cell.2009.05.021","volume":"137","author":"S He","year":"2009","unstructured":"He S, Wang L, Miao L, Wang T, Du F, Zhao L, et al. Receptor interacting protein Kinase-3 determines Cellular necrotic response to TNF-\u03b1. Cell. 2009;137(6):1100\u201311.","journal-title":"Cell"},{"key":"1649_CR31","doi-asserted-by":"publisher","unstructured":"Rodriguez DA, Weinlich R, Brown S, Guy C, Fitzgerald P, Dillon CP et al. Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis. Cell Death Differ [Internet]. 2016;23(1):76\u201388. https:\/\/doi.org\/10.1038\/cdd.2015.70","DOI":"10.1038\/cdd.2015.70"},{"key":"1649_CR32","doi-asserted-by":"publisher","unstructured":"Cai Z, Jitkaew S, Zhao J, Chiang HC, Choksi S, Liu J et al. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol [Internet]. 2013;16(1):55\u201365. http:\/\/www.nature.com\/doifinder\/https:\/\/doi.org\/10.1038\/ncb2883","DOI":"10.1038\/ncb2883"},{"key":"1649_CR33","doi-asserted-by":"publisher","unstructured":"Dondelinger Y, Declercq W, Montessuit S, Roelandt R, Goncalves A, Bruggeman I et al. MLKL Compromises Plasma Membrane Integrity by Binding to Phosphatidylinositol Phosphates. Cell Rep [Internet]. 2014;7(4):971\u201381. https:\/\/doi.org\/10.1016\/j.celrep.2014.04.026","DOI":"10.1016\/j.celrep.2014.04.026"},{"key":"1649_CR34","doi-asserted-by":"publisher","unstructured":"O\u00f1ate M, Catenaccio A, Salvadores N, Saquel C, Martinez A, Moreno-Gonzalez I et al. The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease. Cell Death Differ [Internet]. 2019; https:\/\/doi.org\/10.1038\/s41418-019-0408-4","DOI":"10.1038\/s41418-019-0408-4"},{"issue":"11","key":"1649_CR35","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1016\/j.celrep.2015.02.051","volume":"10","author":"D Ofengeim","year":"2015","unstructured":"Ofengeim D, Ito Y, Najafov A, Zhang Y, Shan B, DeWitt JP, et al. Activation of necroptosis in multiple sclerosis. Cell Rep. 2015;10(11):1836\u201349.","journal-title":"Cell Rep"},{"key":"1649_CR36","doi-asserted-by":"publisher","unstructured":"Ito Y, Ofengeim D, Najafov A, Das S, Saberi S, Li Y et al. RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science (1979) [Internet]. 2016;353(6299):603\u20138. http:\/\/www.sciencemag.org\/lookup\/doi\/https:\/\/doi.org\/10.1126\/science.aaf6803","DOI":"10.1126\/science.aaf6803"},{"issue":"9","key":"1649_CR37","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/nn.4608","volume":"20","author":"A Caccamo","year":"2017","unstructured":"Caccamo A, Branca C, Piras IS, Ferreira E, Huentelman MJ, Liang WS, et al. Necroptosis activation in Alzheimer\u2019s disease. Nat Neurosci. 2017;20(9):1236\u201346.","journal-title":"Nat Neurosci"},{"key":"1649_CR38","doi-asserted-by":"crossref","unstructured":"Jayaraman A, Htike TT, James R, Picon C, Reynolds R. TNF-mediated neuroinflammation is linked to neuronal necroptosis in Alzheimer\u2019s disease hippocampus. Acta Neuropathol Commun. 2021;9(1).","DOI":"10.1186\/s40478-021-01264-w"},{"key":"1649_CR39","doi-asserted-by":"crossref","unstructured":"Koper MJ, Tom\u00e9 SO, Gawor K, Belet A, Van Schoor E, Schaeverbeke J et al. LATE-NC aggravates GVD-mediated necroptosis in Alzheimer\u2019s disease. Acta Neuropathol Commun. 2022;10(1).","DOI":"10.1186\/s40478-022-01432-6"},{"issue":"19","key":"1649_CR40","doi-asserted-by":"publisher","first-page":"9452","DOI":"10.7150\/thno.62376","volume":"11","author":"C Xu","year":"2021","unstructured":"Xu C, Wu J, Wu Y, Ren Z, Yao Y, Chen G, et al. TNF-\u03b1-dependent neuronal necroptosis regulated in Alzheimer\u2019s disease by coordination of RIPK1-p62 complex with autophagic UVRAG. Theranostics. 2021;11(19):9452\u201369.","journal-title":"Theranostics"},{"key":"1649_CR41","doi-asserted-by":"crossref","unstructured":"Salvadores N, Moreno-Gonzalez I, Gamez N, Quiroz G, Vegas-Gomez L, Escand\u00f3n M et al. A\u03b2 oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer\u2019s disease. Acta Neuropathol Commun. 2022;10(1).","DOI":"10.1186\/s40478-022-01332-9"},{"issue":"3","key":"1649_CR42","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00401-019-02103-y","volume":"139","author":"MJ Koper","year":"2020","unstructured":"Koper MJ, Van Schoor E, Ospitalieri S, Vandenberghe R, Vandenbulcke M, von Arnim CAF, et al. Necrosome complex detected in granulovacuolar degeneration is associated with neuronal loss in Alzheimer\u2019s disease. Acta Neuropathol. 2020;139(3):463\u201384.","journal-title":"Acta Neuropathol"},{"issue":"20","key":"1649_CR43","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1021\/acschemneuro.0c00516","volume":"11","author":"TMK Motawi","year":"2020","unstructured":"Motawi TMK, Abdel-Nasser ZM, Shahin NN. Ameliorative effect of Necrosulfonamide in a rat model of Alzheimer\u2019s Disease: targeting mixed lineage kinase domain-like protein-mediated necroptosis. ACS Chem Neurosci. 2020;11(20):3386\u201397.","journal-title":"ACS Chem Neurosci"},{"issue":"5","key":"1649_CR44","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1007\/s10787-023-01269-y","volume":"31","author":"R Abdelhady","year":"2023","unstructured":"Abdelhady R, Younis NS, Ali O, Shehata S, Sayed RH, Nadeem RI. Cognitive enhancing effects of pazopanib in Dgalactose\/ovariectomized Alzheimer\u2019s rat model: insights into the role of RIPK1\/RIPK3\/MLKL necroptosis signaling pathway. Inflammopharmacology. 2023;31(5):2719\u201329.","journal-title":"Inflammopharmacology"},{"issue":"21","key":"1649_CR45","doi-asserted-by":"publisher","first-page":"14957","DOI":"10.1021\/acs.jmedchem.2c01478","volume":"65","author":"Y Sun","year":"2022","unstructured":"Sun Y, Xu L, Shao H, Quan D, Mo Z, Wang J, et al. Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole receptor-interacting protein kinase 1 inhibitor as the treatment for Alzheimer\u2019s Disease. J Med Chem. 2022;65(21):14957\u201369.","journal-title":"J Med Chem"},{"key":"1649_CR46","doi-asserted-by":"crossref","unstructured":"Yu H, Morihara R, Ota-Elliott R, Bian Z, Bian Y, Hu X et al. Injection of exogenous amyloid-\u03b2 oligomers aggravated cognitive deficits, and activated necroptosis, in APP23 transgenic mice. Brain Res. 2023;1821.","DOI":"10.1016\/j.brainres.2023.148565"},{"key":"1649_CR47","doi-asserted-by":"crossref","unstructured":"Yuan S, Li H, Yang C, Xie W, Wang Y, Zhang J et al. DHA attenuates A\u03b2-induced necroptosis through the RIPK1\/RIPK3 signaling pathway in THP-1 monocytes. Biomed Pharmacotherapy. 2020;126.","DOI":"10.1016\/j.biopha.2020.110102"},{"key":"1649_CR48","doi-asserted-by":"crossref","unstructured":"Zou C, Mifflin L, Hu Z, Zhang T, Shan B, Wang H et al. Reduction of mNAT1\/hNAT2 contributes to cerebral endothelial necroptosis and A\u03b2 Accumulation in Alzheimer\u2019s Disease. Cell Rep. 2020;33(10).","DOI":"10.1016\/j.celrep.2020.108447"},{"issue":"41","key":"1649_CR49","doi-asserted-by":"publisher","first-page":"E8788","DOI":"10.1073\/pnas.1714175114","volume":"114","author":"D Ofengeim","year":"2017","unstructured":"Ofengeim D, Mazzitelli S, Ito Y, DeWitt JP, Mifflin L, Zou C, et al. RIPK1 mediates a disease-associated microglial response in Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2017;114(41):E8788\u201397.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1649_CR50","doi-asserted-by":"publisher","unstructured":"Huang Z, Zhou T, Sun X, Zheng Y, Cheng B, Li M et al. Necroptosis in microglia contributes to neuroinflammation and retinal degeneration through TLR4 activation. Cell Death Differ [Internet]. 2018;25(1):180\u20139. https:\/\/doi.org\/10.1038\/cdd.2017.141","DOI":"10.1038\/cdd.2017.141"},{"key":"1649_CR51","unstructured":"Yew B, Nation DA. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia. http:\/\/adni.loni.usc.edu\/wp-content\/uploads\/how_to_apply\/ADNI_Acknowledgement_List.pdf"},{"key":"1649_CR52","doi-asserted-by":"crossref","unstructured":"Dong Y, Yu H, Li X, Bian K, Zheng Y, Dai M et al. Hyperphosphorylated tau mediates neuronal death by inducing necroptosis and inflammation in Alzheimer\u2019s disease. J Neuroinflammation. 2022;19(1).","DOI":"10.1186\/s12974-022-02567-y"},{"issue":"4","key":"1649_CR53","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3233\/JAD-150242","volume":"47","author":"K Liu","year":"2015","unstructured":"Liu K, Chojnacki JE, Wade EE, Saathoff JM, Lesnefsky EJ, Chen Q, et al. Bivalent compound 17MN exerts neuroprotection through interaction at multiple sites in a cellular model of Alzheimer\u2019s disease. J Alzheimer\u2019s Disease. 2015;47(4):1021\u201333.","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"4","key":"1649_CR54","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1007\/s12035-021-02652-y","volume":"59","author":"W Wang","year":"2022","unstructured":"Wang W, Gu X, Cheng Z, Lu X, Xie S, Liu X. IKK\u03b2 Alleviates Neuron Injury in Alzheimer\u2019s Disease via regulating autophagy and RIPK1-Mediated necroptosis. Mol Neurobiol. 2022;59(4):2407\u201323.","journal-title":"Mol Neurobiol"},{"key":"1649_CR55","doi-asserted-by":"crossref","unstructured":"Li XX, Lang XY, Ren TT, Wang J, Lan R, Qin XY. Coeloglossum viride var. Bracteatum extract attenuates A\u03b2-induced toxicity by inhibiting RIP1\u2013driven inflammation and necroptosis. J Ethnopharmacol. 2022;282.","DOI":"10.1016\/j.jep.2021.114606"},{"issue":"6663","key":"1649_CR56","first-page":"1176","volume":"381","author":"S Balusu","year":"2023","unstructured":"Balusu S, Horr\u00e9 K, Thrupp N, Craessaerts K, Snellinx A, Serneels L, et al. MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer\u2019s disease. Sci (1979). 2023;381(6663):1176\u201382.","journal-title":"Sci (1979)"},{"issue":"8","key":"1649_CR57","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1111\/cts.13317","volume":"15","author":"MFJM Vissers","year":"2022","unstructured":"Vissers MFJM, Heuberger JAAC, Groeneveld GJ, Oude Nijhuis J, De Deyn PP, Hadi S, et al. Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I\/Ib studies in healthy subjects and patients. Clin Transl Sci. 2022;15(8):2010\u201323.","journal-title":"Clin Transl Sci"},{"key":"1649_CR58","doi-asserted-by":"crossref","unstructured":"Hincelin-Mery A, Nicolas X, Cantalloube C, Pomponio R, Lewanczyk P, Benamor M et al. Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants. Clin Transl Sci. 2023.","DOI":"10.1111\/cts.13690"},{"key":"1649_CR59","doi-asserted-by":"crossref","unstructured":"Sun ALA, Gillies JD, Shen Y, Deng H, Xue F, Ma Y et al. A phase I randomized study to evaluate safety, pharmacokinetics, and pharmacodynamics of SIR2446M, a selective RIPK1 inhibitor, in healthy participants. Clin Transl Sci. 2024;17(7).","DOI":"10.1111\/cts.13857"},{"key":"1649_CR60","doi-asserted-by":"crossref","unstructured":"Koper MJ, Moonen S, Ronisz A, Ospitalieri S, Callaerts-Vegh Z, T\u2019Syen D et al. Inhibition of an Alzheimer\u2019s disease\u2013associated form of necroptosis rescues neuronal death in mouse models. Sci Transl Med. 2024;16(771).","DOI":"10.1126\/scitranslmed.adf5128"},{"issue":"6","key":"1649_CR61","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/13543784.2017.1323868","volume":"26","author":"D Mehta","year":"2017","unstructured":"Mehta D, Jackson R, Paul G, Shi J, Sabbagh M. Why do trials for Alzheimer\u2019s disease drugs keep failing? A discontinued drug perspective for 2010\u20132015. Expert Opin Investig Drugs. 2017;26(6):735\u20139.","journal-title":"Expert Opin Investig Drugs"},{"key":"1649_CR62","doi-asserted-by":"crossref","unstructured":"Yiannopoulou KG, Anastasiou AI, Zachariou V, Pelidou SH. Reasons for failed trials of disease-modifying treatments for alzheimer disease and their contribution in recent research. Volume 7. Biomedicines. MDPI AG; 2019.","DOI":"10.20944\/preprints201909.0270.v1"},{"issue":"4","key":"1649_CR63","first-page":"398","volume":"8","author":"J Cummings","year":"2021","unstructured":"Cummings J, Aisen P, Apostolova LG, Atri A, Salloway S, Weiner M. Aducanumab: appropriate use recommendations. J Prev Alzheimer\u2019s Disease. 2021;8(4):398\u2013410.","journal-title":"J Prev Alzheimer\u2019s Disease"},{"key":"1649_CR64","doi-asserted-by":"publisher","unstructured":"Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med [Internet]. 2016;8(6):595\u2013608. http:\/\/embomolmed.embopress.org\/lookup\/doi\/https:\/\/doi.org\/10.15252\/emmm.201606210","DOI":"10.15252\/emmm.201606210"},{"key":"1649_CR65","doi-asserted-by":"publisher","unstructured":"Hern\u00e1ndez DE, Salvadores NA, Moya-Alvarado G, Catal\u00e1n RJ, Bronfman FC, Court FA. Axonal degeneration induced by glutamate excitotoxicity is mediated by necroptosis. J Cell Sci [Internet]. 2018;131(22):jcs214684. http:\/\/jcs.biologists.org\/lookup\/doi\/https:\/\/doi.org\/10.1242\/jcs.214684","DOI":"10.1242\/jcs.214684"},{"key":"1649_CR66","doi-asserted-by":"publisher","unstructured":"Arr\u00e1zola MS, Saquel C, Catal\u00e1n RJ, Barrientos SA, Hernandez DE, Mart\u00ednez NW et al. Axonal Degeneration Is Mediated by Necroptosis Activation. The Journal of Neuroscience [Internet]. 2019;39(20):3832\u201344. http:\/\/www.jneurosci.org\/lookup\/doi\/https:\/\/doi.org\/10.1523\/JNEUROSCI.0881-18.2019","DOI":"10.1523\/JNEUROSCI.0881-18.2019"},{"key":"1649_CR67","doi-asserted-by":"crossref","unstructured":"Ko KW, Milbrandt J, DiAntonio A. SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration. Journal of Cell Biology [Internet]. 2020;219(8). https:\/\/rupress.org\/jcb\/article\/219\/8\/e201912047\/151915\/SARM1-acts-downstream-of-neuroinflammatory-and","DOI":"10.1083\/jcb.201912047"},{"key":"1649_CR68","doi-asserted-by":"publisher","unstructured":"Stokin GB. Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer\u2019s Disease. Science (1979) [Internet]. 2005;307(5713):1282\u20138. http:\/\/www.sciencemag.org\/cgi\/doi\/https:\/\/doi.org\/10.1126\/science.1105681","DOI":"10.1126\/science.1105681"},{"key":"1649_CR69","doi-asserted-by":"publisher","unstructured":"Cras P, Kawai M, Lowery D, Gonzalez-DeWhitt P, Greenberg B, Perry G. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proceedings of the National Academy of Sciences [Internet]. 1991;88(17):7552\u20136. http:\/\/www.pnas.org\/cgi\/doi\/https:\/\/doi.org\/10.1073\/pnas.88.17.7552","DOI":"10.1073\/pnas.88.17.7552"},{"issue":"17","key":"1649_CR70","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1097\/00001756-199712010-00006","volume":"8","author":"F Dessi","year":"1997","unstructured":"Dessi F, Colle MA, Hauw JJ, Duyckaerts C. Accumulation of SNAP-25 immunoreactive material in axons of Alzheimer\u2019s disease. NeuroReport. 1997;8(17):3685\u20139.","journal-title":"NeuroReport"},{"key":"1649_CR71","doi-asserted-by":"publisher","unstructured":"Stoub TR, DeToledo-Morrell L, Stebbins GT, Leurgans S, Bennett DA, Shah RC. Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer\u2019s disease. Proceedings of the National Academy of Sciences [Internet]. 2006;103(26):10041\u20135. http:\/\/www.pnas.org\/cgi\/doi\/https:\/\/doi.org\/10.1073\/pnas.0603414103","DOI":"10.1073\/pnas.0603414103"},{"issue":"1\u20132","key":"1649_CR72","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1155\/2009\/408037","volume":"21","author":"EJ Rogalski","year":"2009","unstructured":"Rogalski EJ, Murphy CM, Detoledo-Morrell L, Shah RC, Moseley ME, Bammer R, et al. Changes in parahippocampal white matter integrity in amnestic mild cognitive impairment: a diffusion tensor imaging study. Behav Neurol. 2009;21(1\u20132):51\u201361.","journal-title":"Behav Neurol"},{"issue":"3","key":"1649_CR73","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.neuroimage.2005.10.035","volume":"30","author":"P Kalus","year":"2006","unstructured":"Kalus P, Slotboom J, Gallinat J, Mahlberg R, Cattapan-Ludewig K, Wiest R, et al. Examining the gateway to the limbic system with diffusion tensor imaging: the perforant pathway in dementia. NeuroImage. 2006;30(3):713\u201320.","journal-title":"NeuroImage"}],"container-title":["Alzheimer's Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01649-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-024-01649-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01649-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T02:05:34Z","timestamp":1735178734000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-024-01649-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1649"],"URL":"https:\/\/doi.org\/10.1186\/s13195-024-01649-8","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,26]]},"assertion":[{"value":"2 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"275"}}